Cargando…

Increased Alveolar Heparan Sulphate and Reduced Pulmonary Surfactant Amount and Function in the Mucopolysaccharidosis IIIA Mouse

Mucopolysaccharidosis IIIA (MPS IIIA) is a lysosomal storage disease with significant neurological and skeletal pathologies. Respiratory dysfunction is a secondary pathology contributing to mortality in MPS IIIA patients. Pulmonary surfactant is crucial to optimal lung function and has not been inve...

Descripción completa

Detalles Bibliográficos
Autores principales:	Paget, Tamara L., Parkinson-Lawrence, Emma J., Trim, Paul J., Autilio, Chiara, Panchal, Madhuriben H., Koster, Grielof, Echaide, Mercedes, Snel, Marten F., Postle, Anthony D., Morrison, Janna L., Pérez-Gil, Jésus, Orgeig, Sandra
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8070179/ https://www.ncbi.nlm.nih.gov/pubmed/33918094 http://dx.doi.org/10.3390/cells10040849

Ejemplares similares

Metabolism of a synthetic compared with a natural therapeutic pulmonary surfactant in adult mice
por: Madsen, Jens, et al.
Publicado: (2018)

Distribution of Heparan Sulfate Oligosaccharides in Murine Mucopolysaccharidosis Type IIIA
por: Mason, Kerryn, et al.
Publicado: (2014)

Mass spectrometry imaging of phosphatidylcholine metabolism in lungs administered with therapeutic surfactants and isotopic tracers
por: Ellis, Shane R., et al.
Publicado: (2021)

Rapid Phospholipid Turnover after Surfactant Nebulization in Severe COVID-19 Infection: A Randomized Clinical Trial
por: Postle, Anthony D., et al.
Publicado: (2021)

From hypertransaminasemia to mucopolysaccharidosis IIIA
por: Krawiec, Paulina, et al.
Publicado: (2014)

Intravenous delivery of a chemically modified sulfamidase efficiently reduces heparan sulfate storage and brain pathology in mucopolysaccharidosis IIIA mice
por: Gustavsson, Susanne, et al.
Publicado: (2019)

Prediction of phenotypic severity in mucopolysaccharidosis type IIIA
por: Knottnerus, Suzan J. G., et al.
Publicado: (2017)

Bioinformatics classification of mutations in patients with Mucopolysaccharidosis IIIA
por: Tanwar, Himani, et al.
Publicado: (2019)

Matrix heparan sulphate, but not endothelial cell surface heparan sulphate, is degraded by highly metastatic mouse lymphoma cells.
por: Hennes, R., et al.
Publicado: (1988)

Lentiviral-mediated gene correction of mucopolysaccharidosis type IIIA
por: Anson, Donald S, et al.
Publicado: (2007)

Enhancing the Therapeutic Potential of Sulfamidase for the Treatment of Mucopolysaccharidosis IIIA
por: Sorrentino, Nicolina Cristina, et al.
Publicado: (2019)

Heparan Sulfate, Mucopolysaccharidosis IIIB and Sulfur Metabolism Disorders
por: Kaczor-Kamińska, Marta, et al.
Publicado: (2022)

Uncovering the Relationship between Sulphation Patterns and Conformation of Iduronic Acid in Heparan Sulphate
por: Hsieh, Po-Hung, et al.
Publicado: (2016)

Neuropathology in Mouse Models of Mucopolysaccharidosis Type I, IIIA and IIIB
por: Wilkinson, Fiona L., et al.
Publicado: (2012)

Structure of sulfamidase provides insight into the molecular pathology of mucopolysaccharidosis IIIA
por: Sidhu, Navdeep S., et al.
Publicado: (2014)

Neurocognitive testing in a murine model of mucopolysaccharidosis type IIIA
por: Pericleous, Kleopatra, et al.
Publicado: (2023)

Focal lesions following intracerebral gene therapy for mucopolysaccharidosis IIIA
por: Bugiani, Marianna, et al.
Publicado: (2023)

An immune deficient mouse model for mucopolysaccharidosis IIIA (Sanfilippo syndrome)
por: Pollock, Kari, et al.
Publicado: (2023)

Presence of chondroitin sulphate and requirement for heparan sulphate biosynthesis in the developing zebrafish inner ear
por: Jones, Ana A., et al.
Publicado: (2022)

Heparan sulphate synthetic and editing enzymes in ovarian cancer
por: Backen, A C, et al.
Publicado: (2007)

Heparin, Heparan Sulphate and the TGF-β Cytokine Superfamily
por: Rider, Chris C., et al.
Publicado: (2017)

Validation of Recombinant Heparan Sulphate Reagents for CNS Repair
por: Lindsay, Susan L., et al.
Publicado: (2023)

Overcoming Limitations Inherent in Sulfamidase to Improve Mucopolysaccharidosis IIIA Gene Therapy
por: Chen, Yonghong, et al.
Publicado: (2018)

Sulphation and fibronectin-binding properties of heparan sulphate glycosaminoglycans from transformed cultured human keratinocytes.
por: Brown, K. W.
Publicado: (1987)

Selective Inhibition of Heparan Sulphate and Not Chondroitin Sulphate Biosynthesis by a Small, Soluble Competitive Inhibitor
por: Maciej-Hulme, Marissa L., et al.
Publicado: (2021)

Glycomics Approaches for the Bioassay and Structural Analysis of Heparin/Heparan Sulphates
por: Puvirajesinghe, Tania M., et al.
Publicado: (2012)

Interplay between transglutaminases and heparan sulphate in progressive renal scarring
por: Burhan, Izhar, et al.
Publicado: (2016)

Recent Insights into Cell Surface Heparan Sulphate Proteoglycans and Cancer
por: Couchman, John R, et al.
Publicado: (2016)

Heparin, Heparan Sulphate and Sepsis: Potential New Options for Treatment
por: Hogwood, John, et al.
Publicado: (2023)

Cardiac disease as the presenting feature of mucopolysaccharidosis type IIIA: A case report
por: Ribeiro, Erlane Marques, et al.
Publicado: (2014)

A novel mutation of SGSH and clinical features analysis of mucopolysaccharidosis type IIIA
por: Li, Xiaohua, et al.
Publicado: (2018)

Controlled hypothermia may improve surfactant function in asphyxiated neonates with or without meconium aspiration syndrome
por: Autilio, Chiara, et al.
Publicado: (2018)

Heparan sulphate inhibition of cell proliferation induced by TGFβ and PDGF
por: Silber, lan E., et al.
Publicado: (1993)

Characterization of two heparan sulphate-binding sites in the mycobacterial adhesin Hlp
por: Portugal, Michelle I, et al.
Publicado: (2008)

Bovine Lactoferrin Inhibits Toscana Virus Infection by Binding to Heparan Sulphate
por: Pietrantoni, Agostina, et al.
Publicado: (2015)

Spatiotemporal Localisation of Heparan Sulphate Proteoglycans throughout Mouse Lens Morphogenesis
por: Wishart, Tayler F. L., et al.
Publicado: (2023)

Pteropine orthoreoviruses use cell surface heparan sulphate as an attachment receptor
por: Tan, Chee Wah, et al.
Publicado: (2023)

Differential distribution of heparan sulfate glycoforms and elevated expression of heparan sulfate biosynthetic enzyme genes in the brain of mucopolysaccharidosis IIIB mice
por: McCarty, Douglas M., et al.
Publicado: (2011)

In Vitro Functional and Structural Characterization of A Synthetic Clinical Pulmonary Surfactant with Enhanced Resistance to Inhibition
por: Echaide, Mercedes, et al.
Publicado: (2020)

Heparan Sulfate Inhibits Hematopoietic Stem and Progenitor Cell Migration and Engraftment in Mucopolysaccharidosis I
por: Watson, H. Angharad, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_07d38l3uk8rn06qflrg14lg4ug